• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

北京市社区精神科医生优先推荐长效注射剂的意愿。

The Willingness of Community Psychiatric Management Physicians to Preferentially Recommend Long-Acting Injections in Beijing.

机构信息

School of Public Health, Capital Medical University, Beijing, China.

Research Center for Capital Health Management and Policy, Beijing, China.

出版信息

Front Public Health. 2021 Nov 19;9:779563. doi: 10.3389/fpubh.2021.779563. eCollection 2021.

DOI:10.3389/fpubh.2021.779563
PMID:34869192
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8639574/
Abstract

Severe mental disorders (SMD) impose a heavy burden on individuals, society, and the country. Under the background of deinstitutionalization, more and more patients return to the community, and the community psychiatric management physicians (CPMP) play an essential role in this process. Long-acting injection (LAI) is an important way to improve compliance and reduce re-hospitalization. Some districts in Beijing have implemented the policy of free LAI. This article aims to find out the willingness of CPMP to preferentially recommend LAI and provide suggestions for follow-up promotion. All CPMP in 16 districts of Beijing were surveyed. A self-made electronic questionnaire was used to investigate the willingness to recommend LAI in priority. Descriptive statistics, Chi-square test, and logistic regression were used to analyze the data. The willingness of CPMP to preferentially recommend LAI is up to 80%. Participants aged 40-49, female, with higher self-evaluation of psychiatric management knowledge, managing patients who have used LAI in the past, and working in communities with the free LAI policy have higher willingness to recommend LAI in priority. CPMP in Beijing have a positive attitude toward LAI, and most of them have the willingness to recommend LAI to the patients in priority. The recommendation willingness is the basis of prescription decision-making. Therefore, the coverage of free LAI policy should be further expanded in the future to improve the recommendation willingness and thus improve the injection rate of LAI.

摘要

严重精神障碍(SMD)给个人、社会和国家带来了沉重的负担。在去机构化的背景下,越来越多的患者回到社区,社区精神科管理医师(CPMP)在这一过程中发挥着重要作用。长效注射(LAI)是提高依从性和降低再住院率的重要途径。北京的一些区已经实施了 LAI 免费政策。本文旨在了解 CPMP 优先推荐 LAI 的意愿,并为后续推广提供建议。

对北京市 16 个区的所有 CPMP 进行了调查。使用自制的电子问卷调查 CPMP 优先推荐 LAI 的意愿。采用描述性统计、卡方检验和逻辑回归对数据进行分析。

CPMP 优先推荐 LAI 的意愿高达 80%。年龄在 40-49 岁、女性、自我评估精神病管理知识较高、管理过使用过 LAI 的患者、所在社区有 LAI 免费政策的 CPMP 更愿意优先推荐 LAI。

北京的 CPMP 对 LAI 持积极态度,大多数人愿意优先向患者推荐 LAI。推荐意愿是处方决策的基础。因此,未来应进一步扩大 LAI 免费政策的覆盖范围,以提高推荐意愿,从而提高 LAI 的注射率。

相似文献

1
The Willingness of Community Psychiatric Management Physicians to Preferentially Recommend Long-Acting Injections in Beijing.北京市社区精神科医生优先推荐长效注射剂的意愿。
Front Public Health. 2021 Nov 19;9:779563. doi: 10.3389/fpubh.2021.779563. eCollection 2021.
2
Attitudes and Willingness to Accept Long-Acting Injections for Patients With Schizophrenia in Beijing: A Cross-Sectional Investigation Based on Samples From the Communities.基于社区样本的北京市精神分裂症患者对长效注射治疗的态度和接受意愿的横断面调查
Front Public Health. 2021 Nov 25;9:770276. doi: 10.3389/fpubh.2021.770276. eCollection 2021.
3
Attitudes of European physicians towards the use of long-acting injectable antipsychotics.欧洲医生对长效注射用抗精神病药物使用的态度。
BMC Psychiatry. 2020 Mar 14;20(1):123. doi: 10.1186/s12888-020-02530-2.
4
The willingness of patients to make the first visit to primary care institutions and its influencing factors in Beijing medical alliances: a comparative study of Beijing's medical resource-rich and scarce regions.北京医疗联盟中患者首次就诊于基层医疗机构的意愿及其影响因素:北京医疗资源丰富与稀缺地区的比较研究
BMC Health Serv Res. 2019 Jun 7;19(1):361. doi: 10.1186/s12913-019-4184-0.
5
Predictors of psychiatric hospitalization during 6 months of maintenance treatment with olanzapine long-acting injection: post hoc analysis of a randomized, double-blind study.奥氮平长效注射剂维持治疗 6 个月期间精神病住院的预测因素:一项随机、双盲研究的事后分析。
BMC Psychiatry. 2013 Sep 16;13:224. doi: 10.1186/1471-244X-13-224.
6
Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness.严重精神疾病中长效注射用抗精神病药物的使用与管理指南
BMC Psychiatry. 2013 Dec 20;13:340. doi: 10.1186/1471-244X-13-340.
7
Long-acting injectable antipsychotics: Six-month follow-up of new outpatient treatments in Bologna Community Mental Health Centres.长效注射抗精神病药:博洛尼亚社区精神卫生中心新门诊治疗的 6 个月随访。
PLoS One. 2019 Feb 15;14(2):e0211938. doi: 10.1371/journal.pone.0211938. eCollection 2019.
8
Comparative effectiveness of risperidone long-acting injectable vs first-generation antipsychotic long-acting injectables in schizophrenia: results from a nationwide, retrospective inception cohort study.利培酮长效注射剂与第一代抗精神病长效注射剂治疗精神分裂症的比较疗效:一项全国性回顾性起始队列研究的结果
Schizophr Bull. 2015 May;41(3):627-36. doi: 10.1093/schbul/sbu128. Epub 2014 Sep 1.
9
Comparative effectiveness of long-acting risperidone in New Zealand: a report of resource utilization and costs in a 12-month mirror-image analysis.新西兰长效利培酮的比较效果:12 个月镜像分析中资源利用和成本的报告。
Clin Drug Investig. 2010;30(11):777-87. doi: 10.2165/11537680-000000000-00000.
10
[The role of the general practitioner in management of psychiatric disorders].[全科医生在精神疾病管理中的作用]
Rev Epidemiol Sante Publique. 2020 Jun;68(3):185-192. doi: 10.1016/j.respe.2020.05.002. Epub 2020 May 29.

本文引用的文献

1
The Revolving Door Phenomenon: Psychiatric Hospitalization and Risk of Readmission Among Drug-Addicted Patients.旋转门现象:药物成瘾患者的精神病住院治疗及再入院风险
Clin Ter. 2020 Sep-Oct;171(5):e421-e424. doi: 10.7417/CT.2020.2252.
2
Disentangling relapse and adherence in psychosis.区分精神病中的复发与依从性。
Lancet Psychiatry. 2020 Sep;7(9):722-723. doi: 10.1016/S2215-0366(20)30310-2.
3
Persistent Barriers to the Use of Long-Acting Injectable Antipsychotics for the Treatment of Schizophrenia.长效注射抗精神病药治疗精神分裂症的持续障碍。
J Clin Psychopharmacol. 2020 Jul/Aug;40(4):346-349. doi: 10.1097/JCP.0000000000001225.
4
Attitudes of European physicians towards the use of long-acting injectable antipsychotics.欧洲医生对长效注射用抗精神病药物使用的态度。
BMC Psychiatry. 2020 Mar 14;20(1):123. doi: 10.1186/s12888-020-02530-2.
5
Trends in the incidence and DALYs of schizophrenia at the global, regional and national levels: results from the Global Burden of Disease Study 2017.全球、区域和国家层面精神分裂症发病率和伤残调整寿命年趋势:来自 2017 年全球疾病负担研究的结果。
Epidemiol Psychiatr Sci. 2020 Jan 13;29:e91. doi: 10.1017/S2045796019000891.
6
Perceptions of Psychiatrists Toward the Use of Long-Acting Injectable Antipsychotics: An Online Survey Study From India.印度在线调查研究:精神科医生对使用长效注射抗精神病药的看法。
J Clin Psychopharmacol. 2019 Nov/Dec;39(6):611-619. doi: 10.1097/JCP.0000000000001109.
7
Patients With Early-Phase Schizophrenia Will Accept Treatment With Sustained-Release Medication (Long-Acting Injectable Antipsychotics): Results From the Recruitment Phase of the PRELAPSE Trial.早期精神分裂症患者将接受长效抗精神病药物(长效注射剂)的治疗:PRELAPSE 试验招募阶段的结果。
J Clin Psychiatry. 2019 Apr 23;80(3):18m12546. doi: 10.4088/JCP.18m12546.
8
Improving Long-Term Outcomes in Patients With Schizophrenia: What Is the Evidence for Long-Acting Injectable Antipsychotics?改善精神分裂症患者的长期预后:长效注射用抗精神病药的证据是什么?
J Clin Psychiatry. 2017 Nov/Dec;78(9):e1431. doi: 10.4088/JCP.ot16046tx1cj.
9
China's National Comprehensive Management Pilot Project for Mental Health.中国国家心理健康综合管理试点项目
BJPsych Int. 2017 May 1;14(2):44-46. doi: 10.1192/s2056474000001781. eCollection 2017 May.
10
Integrated mental health services in China: challenges and planning for the future.中国的精神卫生服务整合:未来的挑战与规划。
Health Policy Plan. 2018 Jan 1;33(1):107-122. doi: 10.1093/heapol/czx137.